SCHEMBL87985

SCHEMBL87985

C=CCOC(CC=C)C(O)CO

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22495180 0.87 CA1 (0.33) CA1CA2CA7
SCHEMBL5180462 0.86
SCHEMBL8906227 0.85 TDP1 (0.43)
SCHEMBL97667 0.80 LMNA (0.33)
SCHEMBL3294481 0.80 CA1 (0.46) CA1CA2CA7
SCHEMBL28851209 0.80 CA1 (0.46) CA1CA2CA7
SCHEMBL3264113 0.80
SCHEMBL7690798 0.79
SCHEMBL29080691 0.77 LMNA (0.31)
SCHEMBL28469184 0.77 TDP1 (0.33) CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4017 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226026-A1 BRANCHED TAIL LIPID COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS ARES CAPITAL CORPORATION, AS AGENT 2024-07-11 US claimed
WO-2024145963-A1 IONIZABLE CATIONIC LIPID COMPOUND AND COMPOSITION FOR DELIVERING NUCLEIC ACID AND USE THEREOF 北京悦康科创医药科技股份有限公司 2024-07-11 WO claimed
WO-2024147060-A1 NOVEL IONIZABLE LIPID COMPOUNDS FOR NUCLEIC ACID DELIVERY CELON PHARMA S.A. (PL) 2024-07-11 WO claimed
WO-2024145965-A1 LONG-ACTING LOW-TOXICITY NOVEL CATIONIC LIPID COMPOUNDS AND COMPOSITION THEREOF 北京悦康科创医药科技股份有限公司 2024-07-11 WO claimed
WO-2024145964-A1 CATIONIC LIPID COMPOUND WITH HIGH EFFICIENCY, LOW TOXICITY AND STABLE EXPRESSION, AND COMPOSITION COMPRISING SAME 北京悦康科创医药科技股份有限公司 2024-07-11 WO claimed
CN-118317945-A Multi-motif dendrons and their supramolecular structures and uses thereof 多伦多大学管理委员会 2024-07-09 CN claimed
WO-2024140835-A1 LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION 仁景(苏州)生物科技有限公司 2024-07-04 WO claimed
WO-2024145290-A2 MODULAR LIPID COMPOUNDS AND TWO- TO THREE-COMPONENT LIPID NANOPARTICLE COMPOSITIONS SUNVAX MRNA THERAPEUTICS (US) 2024-07-04 WO claimed
CN-118255678-A Ionizable lipid compound and application thereof 荣灿生物医药技术(上海)有限公司 2024-06-28 CN claimed
WO-2024134511-A2 LIPID NANOPARTICLE COMPOSITION Seqirus Inc. (US) 2024-06-27 WO claimed
US-5744461-A VIRICIDES NEXSTAR PHARMACEUTICALS, INC. (US) 1998-04-28 US claimed
WO-1998016540-A1 IMPROVED COUPLING ACTIVATORS FOR OLIGONUCLEOTIDE SYNTHESIS PROLIGO LLC (US) 1998-04-23 WO claimed
EP-0571724-B1 Stabilizer for phospholipid vesicles CHIBA FLOUR MILLING (JP) 1997-06-04 EP claimed
JP-H08504439-A 1996-05-14 JP claimed
EP-0674646-A4 LIPID DERIVATIVES OF PHOSPHONOACIDS FOR LIPOSOMAL INCORPORATION AND METHOD OF USE. VESTAR INC (US) 1996-01-17 EP claimed
US-5463092-A Viricides VESTAR, INC. (US) 1995-10-31 US claimed
EP-0674646-A1 LIPID DERIVATIVES OF PHOSPHONOACIDS FOR LIPOSOMAL INCORPORATION AND METHOD OF USE NeXstar Pharmaceuticals, Inc. (US) 1995-10-04 EP claimed
US-5438125-A For treating nervous system disorders NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1995-08-01 US claimed
WO-1994013682-A1 LIPID DERIVATIVES OF PHOSPHONOACIDS FOR LIPOSOMAL INCORPORATION AND METHOD OF USE VESTAR, INC. (US) 1994-06-23 WO claimed
EP-0502827-A1 Sialic acid derivatives NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) 1992-09-09 EP claimed